Cargando…

Synthesis, anticancer and apoptosis-inducing activities of quinazoline–isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies

A new series of quinazolinone compounds 16–34 incorporating isatin moieties was synthesized. The antitumor efficacy of the compounds against MDA-MB-231, a breast cancer cell line, and LOVO, a colon cancer cell line, was assessed. Compounds 20, 21, 22, 23, 25, 27, 28, 29, 30, 31, 32, 33, and 34 displ...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Azab, Adel S., Al-Dhfyan, Abdullah, Abdel-Aziz, Alaa A.-M., Abou-Zeid, Laila A., Alkahtani, Hamad M., Al-Obaid, Abdulrahman M., Al-Gendy, Manal A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445199/ https://www.ncbi.nlm.nih.gov/pubmed/28718672 http://dx.doi.org/10.1080/14756366.2017.1344981

Ejemplares similares

Synthesis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activities of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine scaffolds: a molecular docking study
por: Abdel-Aziz, Alaa A.-M., et al.
Publicado: (2020)

Carbonic Anhydrase Inhibition Activities of Schiff’s Bases Based on Quinazoline-Linked Benzenesulfonamide
por: El-Azab, Adel S., et al.
Publicado: (2022)

Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues
por: El-Azab, Adel S., et al.
Publicado: (2017)

Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies
por: El-Azab, Adel S., et al.
Publicado: (2018)

Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents
por: Eldehna, Wagdy M., et al.
Publicado: (2017)

2-(2-{[4-Oxo-3-(2-phenylethyl)-3,4-dihydroquinazolin-2-yl]sulfanyl}ethyl)-2,3-dihydro-1H-isoindole-1,3-dione
por: El-Azab, Adel S., et al.
Publicado: (2012)

Synthesis, potential antitumor activity, cell cycle analysis, and multitarget mechanisms of novel hydrazones incorporating a 4-methylsulfonylbenzene scaffold: a molecular docking study
por: Abdel-Aziz, Alaa A.-M., et al.
Publicado: (2021)

Schiff bases of indoline-2,3-dione (isatin) with potential antiproliferative activity
por: Aboul-Fadl, Tarek, et al.
Publicado: (2012)

Synthesis, Anticancer Screening of Some Novel Trimethoxy Quinazolines and VEGFR2, EGFR Tyrosine Kinase Inhibitors Assay; Molecular Docking Studies
por: Altamimi, Abdulmalik S., et al.
Publicado: (2021)

2-Methylsulfanyl-9H-1,3,4-thiadiazolo[2,3-b]quinazolin-9-one
por: El-Azab, Adel S., et al.
Publicado: (2012)

LC–MS/MS method for the quantitation of decitabine and venetoclax in rat plasma after SPE: Application to pharmacokinetic study
por: Alnasser, Abdulaziz I., et al.
Publicado: (2023)

2-{[2-Methyl-3-(2-methylphenyl)-4-oxo-3,4-dihydroquinazolin-8-yl]oxy}acetonitrile
por: El-Azab, Adel S., et al.
Publicado: (2012)

Methyl 3-[(6-nitro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)sulfanyl]propanoate
por: Al-Suwaidan, Ibrahim A., et al.
Publicado: (2013)

Molecular Docking and Anticonvulsant Activity of Newly Synthesized Quinazoline Derivatives
por: Abuelizz, Hatem A., et al.
Publicado: (2017)

Design, synthesis, and carbonic anhydrase inhibition activities of Schiff bases incorporating benzenesulfonamide scaffold: Molecular docking application
por: El-Azab, Adel S., et al.
Publicado: (2023)

Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived Compound Contributes to the Increase of the Chemosensitivity of MCF7/ADR-Resistant Cells to Doxorubicin
por: Abdalla, Ashraf N., et al.
Publicado: (2021)

Benzo[g]quinazolines as antifungal against candidiasis: Screening, molecular docking, and QSAR investigations
por: Abuelizz, Hatem A., et al.
Publicado: (2023)

5-Isopropylimidazolidine-2,4-dione monohydrate
por: Abdel-Aziz, Alaa A.-M., et al.
Publicado: (2012)

A Series of Isatin-Hydrazones with Cytotoxic Activity and CDK2 Kinase Inhibitory Activity: A Potential Type II ATP Competitive Inhibitor
por: Al-Salem, Huda S., et al.
Publicado: (2020)

2-Methyl-3-(2-methylphenyl)-7-nitroquinazolin-4(3H)-one
por: El-Azab, Adel S., et al.
Publicado: (2012)

8-Benzyloxy-2-methyl-3-(2-methylphenyl)quinazolin-4(3H)-one
por: El-Azab, Adel S., et al.
Publicado: (2012)

6-Methyl-3-phenyl-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-4-one
por: El-Azab, Adel S., et al.
Publicado: (2012)

2-Methyl-3-(2-methylphenyl)-4-oxo-3,4-dihydroquinazolin-8-yl benzoate
por: El-Azab, Adel S., et al.
Publicado: (2012)

The Antiproliferative and Apoptotic Effects of a Novel Quinazoline Carrying Substituted-Sulfonamides: In Vitro and Molecular Docking Study
por: Alqahtani, Ali S., et al.
Publicado: (2022)

Synthesis of hapten, generation of specific polyclonal antibody and development of ELISA with high sensitivity for therapeutic monitoring of crizotinib
por: Al-Shehri, Mona M., et al.
Publicado: (2019)

Design, synthesis and molecular modeling of isatin-aminobenzoic acid hybrids as antibacterial and antibiofilm agents
por: Radwan, Awwad A., et al.
Publicado: (2023)

Synthesis, anticancer, apoptosis-inducing activities and EGFR and VEGFR2 assay mechanistic studies of 5,5-diphenylimidazolidine-2,4-dione derivatives: Molecular docking studies
por: Alkahtani, Hamad M., et al.
Publicado: (2019)

2-Methyl-3-(2-methylphenyl)-4-oxo-3,4-dihydroquinazolin-8-yl 4-methylbenzoate
por: El-Azab, Adel S., et al.
Publicado: (2012)

2-Methyl-3-(2-methylphenyl)-4-oxo-3,4-dihydroquinazolin-8-yl thiophene-2-carboxylate
por: El-Azab, Adel S., et al.
Publicado: (2012)

2-Methyl-3-(2-methylphenyl)-4-oxo-3,4-dihydroquinazolin-8-yl 4-bromobenzene-1-sulfonate
por: El-Azab, Adel S., et al.
Publicado: (2012)

2-Methyl-3-(2-methylphenyl)-4-oxo-3,4-dihydroquinazolin-8-yl 4-chlorobenzoate
por: El-Azab, Adel S., et al.
Publicado: (2012)

Facile method for the synthesis of silver nanoparticles using 3-hydrazino-isatin derivatives in aqueous methanol and their antibacterial activity
por: El-Faham, Ayman, et al.
Publicado: (2014)

N-Benzylisatin
por: Schutte, M., et al.
Publicado: (2012)

Antiviral activity of some benzo[g]quinazolines against coxsackievirus B4: biological screening and docking study
por: Abuelizz, Hatem A., et al.
Publicado: (2023)

Synthesis, Anti-microbial and Molecular Docking Studies of Quinazolin-4(3H)-one Derivatives
por: Mabkhot, Yahia Nasser, et al.
Publicado: (2014)

Synthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibition
por: El-Husseiny, Walaa M., et al.
Publicado: (2020)

Molecular docking study and antiviral evaluation of 2-thioxo-benzo[g]quinazolin-4(3H)-one derivatives
por: Al-Salahi, Rashad, et al.
Publicado: (2016)

Antiproliferative Activity, Multikinase Inhibition, Apoptosis- Inducing Effects and Molecular Docking of Novel Isatin–Purine Hybrids
por: Alanazi, Ashwag S., et al.
Publicado: (2023)

Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens
por: Al-Warhi, Tarfah, et al.
Publicado: (2022)

S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors
por: El-Azab, Adel S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_atv7f2msd4k0hmhcmc2ll7a06l